Vanberra Signal
Free trial

CogniScent

Curated by Signal

Provider of AI-based platform for early detection of neurodegenerative diseases

Health Technologycogniscent.io

Overview

CogniScent provides a diagnostic platform. The platform is based on artificial intelligence and helps in the detection of neurodegenerative diseases like Alzheimer's and Parkinson's. The platform uses machine learning algorithms to identify patterns that are central to the classification of patients at risk.

Key facts

Founded
2018
Headquarters
Berlin, Germany
Stage
Sign up to view
Industry
Health Technology

Contact

Primary office
Sign up to view
Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Long-Covid

    Provider of application for COVID-19 symptom checkers

    Health TechnologyGermany

  • eatenet

    Provider of application for nutrition tracking and weight loss

    Health TechnologyRosenheim, Germany

  • Apotheker

    Online pharmacy store

    Health TechnologyGermany

About CogniScent

What does CogniScent do?

CogniScent provides a diagnostic platform.

Where is CogniScent headquartered?

CogniScent is headquartered in Berlin, Germany.

When was CogniScent founded?

CogniScent was founded in 2018.

Which sector is CogniScent in?

CogniScent operates in Health Technology.

Who are CogniScent's competitors?

Companies similar to CogniScent include Long-Covid, eatenet, and Apotheker.